EquitAI LogoEquitAI
$72.72
-1.66%
CYTK

CYTK

Cytokinetics, Incorporated

Healthcare
Loading Chart...
FIT ANALYSIS
Required for personalization
STOCK DNA
Valuation
7/10
Quality
4/10
Growth
3/10
Strength
2/10
Dividend
1/10
Price Trend
Upwards
Momentum
Neutral
Balance Sheet
Distressed (Neg. Equity)
Earnings
Stable
Dividend Yield
0.00%
Market Cap
$10.11B
TALK TO YOUR STOCK
EQUITAI ASSISTANT

Cytokinetics is a biopharmaceutical company that discovers and develops muscle-activating drugs to treat cardiovascular and neuromuscular diseases. Its primary focus is on bringing its late-stage heart medications to market to help patients with severely compromised cardiac function. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.
Talk to Your Stockopen live chat
Pro EquitAI Research
Retrieving premium status...